nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—Lung infiltration—Hydroxyurea—head and neck cancer	0.0283	0.0283	CcSEcCtD
Foscarnet—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.025	0.025	CcSEcCtD
Foscarnet—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.0214	0.0214	CcSEcCtD
Foscarnet—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.0209	0.0209	CcSEcCtD
Foscarnet—Sinus tachycardia—Docetaxel—head and neck cancer	0.0171	0.0171	CcSEcCtD
Foscarnet—Skin ulcer—Hydroxyurea—head and neck cancer	0.017	0.017	CcSEcCtD
Foscarnet—Rectal haemorrhage—Vinblastine—head and neck cancer	0.0161	0.0161	CcSEcCtD
Foscarnet—Neoplasm—Vinblastine—head and neck cancer	0.0132	0.0132	CcSEcCtD
Foscarnet—Blood urea increased—Hydroxyurea—head and neck cancer	0.0125	0.0125	CcSEcCtD
Foscarnet—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0121	0.0121	CcSEcCtD
Foscarnet—Neoplasm—Hydroxyurea—head and neck cancer	0.012	0.012	CcSEcCtD
Foscarnet—Renal failure acute—Hydroxyurea—head and neck cancer	0.0104	0.0104	CcSEcCtD
Foscarnet—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.0101	0.0101	CcSEcCtD
Foscarnet—Face oedema—Hydroxyurea—head and neck cancer	0.0093	0.0093	CcSEcCtD
Foscarnet—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00902	0.00902	CcSEcCtD
Foscarnet—Rash erythematous—Docetaxel—head and neck cancer	0.009	0.009	CcSEcCtD
Foscarnet—Coma—Fluorouracil—head and neck cancer	0.00873	0.00873	CcSEcCtD
Foscarnet—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00868	0.00868	CcSEcCtD
Foscarnet—Pancytopenia—Vinblastine—head and neck cancer	0.00867	0.00867	CcSEcCtD
Foscarnet—Rigors—Docetaxel—head and neck cancer	0.00844	0.00844	CcSEcCtD
Foscarnet—Sepsis—Fluorouracil—head and neck cancer	0.00829	0.00829	CcSEcCtD
Foscarnet—Pancreatitis—Hydroxyurea—head and neck cancer	0.00816	0.00816	CcSEcCtD
Foscarnet—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00798	0.00798	CcSEcCtD
Foscarnet—Pancytopenia—Hydroxyurea—head and neck cancer	0.0079	0.0079	CcSEcCtD
Foscarnet—Dysuria—Hydroxyurea—head and neck cancer	0.00778	0.00778	CcSEcCtD
Foscarnet—Neutropenia—Hydroxyurea—head and neck cancer	0.00778	0.00778	CcSEcCtD
Foscarnet—Agranulocytosis—Vinblastine—head and neck cancer	0.00759	0.00759	CcSEcCtD
Foscarnet—Amnesia—Fluorouracil—head and neck cancer	0.00738	0.00738	CcSEcCtD
Foscarnet—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00727	0.00727	CcSEcCtD
Foscarnet—Hypoaesthesia—Vinblastine—head and neck cancer	0.00727	0.00727	CcSEcCtD
Foscarnet—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00725	0.00725	CcSEcCtD
Foscarnet—Pharyngitis—Vinblastine—head and neck cancer	0.00725	0.00725	CcSEcCtD
Foscarnet—Respiratory failure—Docetaxel—head and neck cancer	0.00702	0.00702	CcSEcCtD
Foscarnet—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00689	0.00689	CcSEcCtD
Foscarnet—Influenza like illness—Docetaxel—head and neck cancer	0.00669	0.00669	CcSEcCtD
Foscarnet—Hallucination—Hydroxyurea—head and neck cancer	0.00663	0.00663	CcSEcCtD
Foscarnet—Cardiac arrest—Fluorouracil—head and neck cancer	0.00659	0.00659	CcSEcCtD
Foscarnet—Candida infection—Docetaxel—head and neck cancer	0.00658	0.00658	CcSEcCtD
Foscarnet—Ataxia—Fluorouracil—head and neck cancer	0.00652	0.00652	CcSEcCtD
Foscarnet—Neuropathy—Docetaxel—head and neck cancer	0.00647	0.00647	CcSEcCtD
Foscarnet—Neoplasm—Docetaxel—head and neck cancer	0.00623	0.00623	CcSEcCtD
Foscarnet—Muscular weakness—Fluorouracil—head and neck cancer	0.00611	0.00611	CcSEcCtD
Foscarnet—Dysphagia—Fluorouracil—head and neck cancer	0.00599	0.00599	CcSEcCtD
Foscarnet—Sepsis—Docetaxel—head and neck cancer	0.00598	0.00598	CcSEcCtD
Foscarnet—Chills—Hydroxyurea—head and neck cancer	0.00598	0.00598	CcSEcCtD
Foscarnet—Ill-defined disorder—Vinblastine—head and neck cancer	0.0059	0.0059	CcSEcCtD
Foscarnet—Anaemia—Vinblastine—head and neck cancer	0.00588	0.00588	CcSEcCtD
Foscarnet—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00575	0.00575	CcSEcCtD
Foscarnet—Malaise—Vinblastine—head and neck cancer	0.00573	0.00573	CcSEcCtD
Foscarnet—Leukopenia—Vinblastine—head and neck cancer	0.00569	0.00569	CcSEcCtD
Foscarnet—Pancytopenia—Fluorouracil—head and neck cancer	0.00569	0.00569	CcSEcCtD
Foscarnet—Convulsion—Vinblastine—head and neck cancer	0.00551	0.00551	CcSEcCtD
Foscarnet—Hypertension—Vinblastine—head and neck cancer	0.00549	0.00549	CcSEcCtD
Foscarnet—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00538	0.00538	CcSEcCtD
Foscarnet—Anaemia—Hydroxyurea—head and neck cancer	0.00536	0.00536	CcSEcCtD
Foscarnet—Discomfort—Vinblastine—head and neck cancer	0.00535	0.00535	CcSEcCtD
Foscarnet—Renal impairment—Docetaxel—head and neck cancer	0.00526	0.00526	CcSEcCtD
Foscarnet—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00524	0.00524	CcSEcCtD
Foscarnet—Dermatitis bullous—Docetaxel—head and neck cancer	0.00523	0.00523	CcSEcCtD
Foscarnet—Malaise—Hydroxyurea—head and neck cancer	0.00523	0.00523	CcSEcCtD
Foscarnet—Urinary tract infection—Fluorouracil—head and neck cancer	0.00519	0.00519	CcSEcCtD
Foscarnet—Conjunctivitis—Fluorouracil—head and neck cancer	0.00519	0.00519	CcSEcCtD
Foscarnet—Leukopenia—Hydroxyurea—head and neck cancer	0.00519	0.00519	CcSEcCtD
Foscarnet—Thrombocytopenia—Vinblastine—head and neck cancer	0.00508	0.00508	CcSEcCtD
Foscarnet—Convulsion—Hydroxyurea—head and neck cancer	0.00502	0.00502	CcSEcCtD
Foscarnet—Hyponatraemia—Docetaxel—head and neck cancer	0.00502	0.00502	CcSEcCtD
Foscarnet—Sinusitis—Fluorouracil—head and neck cancer	0.00501	0.00501	CcSEcCtD
Foscarnet—Agranulocytosis—Fluorouracil—head and neck cancer	0.00498	0.00498	CcSEcCtD
Foscarnet—Anorexia—Vinblastine—head and neck cancer	0.00495	0.00495	CcSEcCtD
Foscarnet—Discomfort—Hydroxyurea—head and neck cancer	0.00488	0.00488	CcSEcCtD
Foscarnet—Rhinitis—Fluorouracil—head and neck cancer	0.00481	0.00481	CcSEcCtD
Foscarnet—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00477	0.00477	CcSEcCtD
Foscarnet—Pharyngitis—Fluorouracil—head and neck cancer	0.00476	0.00476	CcSEcCtD
Foscarnet—Oedema—Hydroxyurea—head and neck cancer	0.00473	0.00473	CcSEcCtD
Foscarnet—Ataxia—Docetaxel—head and neck cancer	0.0047	0.0047	CcSEcCtD
Foscarnet—Infection—Hydroxyurea—head and neck cancer	0.0047	0.0047	CcSEcCtD
Foscarnet—Paraesthesia—Vinblastine—head and neck cancer	0.00466	0.00466	CcSEcCtD
Foscarnet—Dehydration—Docetaxel—head and neck cancer	0.00465	0.00465	CcSEcCtD
Foscarnet—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00463	0.00463	CcSEcCtD
Foscarnet—Anorexia—Hydroxyurea—head and neck cancer	0.00451	0.00451	CcSEcCtD
Foscarnet—Decreased appetite—Vinblastine—head and neck cancer	0.00451	0.00451	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00451	0.00451	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00451	0.00451	CcSEcCtD
Foscarnet—Constipation—Vinblastine—head and neck cancer	0.00444	0.00444	CcSEcCtD
Foscarnet—Pain—Vinblastine—head and neck cancer	0.00444	0.00444	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00441	0.00441	CcSEcCtD
Foscarnet—Dysphagia—Docetaxel—head and neck cancer	0.00432	0.00432	CcSEcCtD
Foscarnet—Feeling abnormal—Vinblastine—head and neck cancer	0.00428	0.00428	CcSEcCtD
Foscarnet—Bronchospasm—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Foscarnet—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00424	0.00424	CcSEcCtD
Foscarnet—Dyspnoea—Hydroxyurea—head and neck cancer	0.00422	0.00422	CcSEcCtD
Foscarnet—Somnolence—Hydroxyurea—head and neck cancer	0.00421	0.00421	CcSEcCtD
Foscarnet—Dyspepsia—Hydroxyurea—head and neck cancer	0.00417	0.00417	CcSEcCtD
Foscarnet—Decreased appetite—Hydroxyurea—head and neck cancer	0.00411	0.00411	CcSEcCtD
Foscarnet—Pancytopenia—Docetaxel—head and neck cancer	0.00411	0.00411	CcSEcCtD
Foscarnet—Abdominal pain—Vinblastine—head and neck cancer	0.0041	0.0041	CcSEcCtD
Foscarnet—Fatigue—Hydroxyurea—head and neck cancer	0.00408	0.00408	CcSEcCtD
Foscarnet—Pain—Hydroxyurea—head and neck cancer	0.00405	0.00405	CcSEcCtD
Foscarnet—Constipation—Hydroxyurea—head and neck cancer	0.00405	0.00405	CcSEcCtD
Foscarnet—Neutropenia—Docetaxel—head and neck cancer	0.00404	0.00404	CcSEcCtD
Foscarnet—Weight decreased—Docetaxel—head and neck cancer	0.00391	0.00391	CcSEcCtD
Foscarnet—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0039	0.0039	CcSEcCtD
Foscarnet—Anaemia—Fluorouracil—head and neck cancer	0.00386	0.00386	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00382	0.00382	CcSEcCtD
Foscarnet—Renal failure—Docetaxel—head and neck cancer	0.00379	0.00379	CcSEcCtD
Foscarnet—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00378	0.00378	CcSEcCtD
Foscarnet—Conjunctivitis—Docetaxel—head and neck cancer	0.00375	0.00375	CcSEcCtD
Foscarnet—Body temperature increased—Hydroxyurea—head and neck cancer	0.00374	0.00374	CcSEcCtD
Foscarnet—Leukopenia—Fluorouracil—head and neck cancer	0.00374	0.00374	CcSEcCtD
Foscarnet—Asthenia—Vinblastine—head and neck cancer	0.00372	0.00372	CcSEcCtD
Foscarnet—Convulsion—Fluorouracil—head and neck cancer	0.00362	0.00362	CcSEcCtD
Foscarnet—Agranulocytosis—Docetaxel—head and neck cancer	0.0036	0.0036	CcSEcCtD
Foscarnet—Chest pain—Fluorouracil—head and neck cancer	0.00355	0.00355	CcSEcCtD
Foscarnet—Myalgia—Fluorouracil—head and neck cancer	0.00355	0.00355	CcSEcCtD
Foscarnet—Diarrhoea—Vinblastine—head and neck cancer	0.00355	0.00355	CcSEcCtD
Foscarnet—Discomfort—Fluorouracil—head and neck cancer	0.00351	0.00351	CcSEcCtD
Foscarnet—Rhinitis—Docetaxel—head and neck cancer	0.00347	0.00347	CcSEcCtD
Foscarnet—Hypoaesthesia—Docetaxel—head and neck cancer	0.00344	0.00344	CcSEcCtD
Foscarnet—Confusional state—Fluorouracil—head and neck cancer	0.00344	0.00344	CcSEcCtD
Foscarnet—Pharyngitis—Docetaxel—head and neck cancer	0.00344	0.00344	CcSEcCtD
Foscarnet—Dizziness—Vinblastine—head and neck cancer	0.00343	0.00343	CcSEcCtD
Foscarnet—Oedema—Fluorouracil—head and neck cancer	0.00341	0.00341	CcSEcCtD
Foscarnet—Asthenia—Hydroxyurea—head and neck cancer	0.0034	0.0034	CcSEcCtD
Foscarnet—Urethral disorder—Docetaxel—head and neck cancer	0.00339	0.00339	CcSEcCtD
Foscarnet—Infection—Fluorouracil—head and neck cancer	0.00338	0.00338	CcSEcCtD
Foscarnet—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00334	0.00334	CcSEcCtD
Foscarnet—Vomiting—Vinblastine—head and neck cancer	0.0033	0.0033	CcSEcCtD
Foscarnet—Erythema multiforme—Docetaxel—head and neck cancer	0.00327	0.00327	CcSEcCtD
Foscarnet—Headache—Vinblastine—head and neck cancer	0.00325	0.00325	CcSEcCtD
Foscarnet—Anorexia—Fluorouracil—head and neck cancer	0.00325	0.00325	CcSEcCtD
Foscarnet—Diarrhoea—Hydroxyurea—head and neck cancer	0.00324	0.00324	CcSEcCtD
Foscarnet—Eye disorder—Docetaxel—head and neck cancer	0.00323	0.00323	CcSEcCtD
Foscarnet—Flushing—Docetaxel—head and neck cancer	0.00321	0.00321	CcSEcCtD
Foscarnet—Hypotension—Fluorouracil—head and neck cancer	0.00318	0.00318	CcSEcCtD
Foscarnet—Dizziness—Hydroxyurea—head and neck cancer	0.00313	0.00313	CcSEcCtD
Foscarnet—Chills—Docetaxel—head and neck cancer	0.00311	0.00311	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0031	0.0031	CcSEcCtD
Foscarnet—Nausea—Vinblastine—head and neck cancer	0.00308	0.00308	CcSEcCtD
Foscarnet—Insomnia—Fluorouracil—head and neck cancer	0.00308	0.00308	CcSEcCtD
Foscarnet—Paraesthesia—Fluorouracil—head and neck cancer	0.00306	0.00306	CcSEcCtD
Foscarnet—Dyspnoea—Fluorouracil—head and neck cancer	0.00304	0.00304	CcSEcCtD
Foscarnet—Somnolence—Fluorouracil—head and neck cancer	0.00303	0.00303	CcSEcCtD
Foscarnet—Vomiting—Hydroxyurea—head and neck cancer	0.00301	0.00301	CcSEcCtD
Foscarnet—Dyspepsia—Fluorouracil—head and neck cancer	0.003	0.003	CcSEcCtD
Foscarnet—Rash—Hydroxyurea—head and neck cancer	0.00298	0.00298	CcSEcCtD
Foscarnet—Dermatitis—Hydroxyurea—head and neck cancer	0.00298	0.00298	CcSEcCtD
Foscarnet—Headache—Hydroxyurea—head and neck cancer	0.00297	0.00297	CcSEcCtD
Foscarnet—Decreased appetite—Fluorouracil—head and neck cancer	0.00296	0.00296	CcSEcCtD
Foscarnet—Back pain—Docetaxel—head and neck cancer	0.00291	0.00291	CcSEcCtD
Foscarnet—Pain—Fluorouracil—head and neck cancer	0.00291	0.00291	CcSEcCtD
Foscarnet—Muscle spasms—Docetaxel—head and neck cancer	0.0029	0.0029	CcSEcCtD
Foscarnet—Nausea—Hydroxyurea—head and neck cancer	0.00281	0.00281	CcSEcCtD
Foscarnet—Feeling abnormal—Fluorouracil—head and neck cancer	0.00281	0.00281	CcSEcCtD
Foscarnet—Anaemia—Docetaxel—head and neck cancer	0.00278	0.00278	CcSEcCtD
Foscarnet—Leukopenia—Docetaxel—head and neck cancer	0.0027	0.0027	CcSEcCtD
Foscarnet—Body temperature increased—Fluorouracil—head and neck cancer	0.00269	0.00269	CcSEcCtD
Foscarnet—Palpitations—Docetaxel—head and neck cancer	0.00266	0.00266	CcSEcCtD
Foscarnet—Cough—Docetaxel—head and neck cancer	0.00263	0.00263	CcSEcCtD
Foscarnet—Convulsion—Docetaxel—head and neck cancer	0.00261	0.00261	CcSEcCtD
Foscarnet—Hypertension—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Foscarnet—Chest pain—Docetaxel—head and neck cancer	0.00257	0.00257	CcSEcCtD
Foscarnet—Myalgia—Docetaxel—head and neck cancer	0.00257	0.00257	CcSEcCtD
Foscarnet—Arthralgia—Docetaxel—head and neck cancer	0.00257	0.00257	CcSEcCtD
Foscarnet—Dry mouth—Docetaxel—head and neck cancer	0.00251	0.00251	CcSEcCtD
Foscarnet—Confusional state—Docetaxel—head and neck cancer	0.00248	0.00248	CcSEcCtD
Foscarnet—Oedema—Docetaxel—head and neck cancer	0.00246	0.00246	CcSEcCtD
Foscarnet—Infection—Docetaxel—head and neck cancer	0.00244	0.00244	CcSEcCtD
Foscarnet—Pruritus—Fluorouracil—head and neck cancer	0.00241	0.00241	CcSEcCtD
Foscarnet—Thrombocytopenia—Docetaxel—head and neck cancer	0.00241	0.00241	CcSEcCtD
Foscarnet—Anorexia—Docetaxel—head and neck cancer	0.00234	0.00234	CcSEcCtD
Foscarnet—Diarrhoea—Fluorouracil—head and neck cancer	0.00233	0.00233	CcSEcCtD
Foscarnet—Hypotension—Docetaxel—head and neck cancer	0.0023	0.0023	CcSEcCtD
Foscarnet—Dizziness—Fluorouracil—head and neck cancer	0.00225	0.00225	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00224	0.00224	CcSEcCtD
Foscarnet—Insomnia—Docetaxel—head and neck cancer	0.00222	0.00222	CcSEcCtD
Foscarnet—Paraesthesia—Docetaxel—head and neck cancer	0.00221	0.00221	CcSEcCtD
Foscarnet—Dyspnoea—Docetaxel—head and neck cancer	0.00219	0.00219	CcSEcCtD
Foscarnet—Somnolence—Docetaxel—head and neck cancer	0.00219	0.00219	CcSEcCtD
Foscarnet—Vomiting—Fluorouracil—head and neck cancer	0.00217	0.00217	CcSEcCtD
Foscarnet—Dyspepsia—Docetaxel—head and neck cancer	0.00216	0.00216	CcSEcCtD
Foscarnet—Rash—Fluorouracil—head and neck cancer	0.00215	0.00215	CcSEcCtD
Foscarnet—Dermatitis—Fluorouracil—head and neck cancer	0.00215	0.00215	CcSEcCtD
Foscarnet—Decreased appetite—Docetaxel—head and neck cancer	0.00214	0.00214	CcSEcCtD
Foscarnet—Headache—Fluorouracil—head and neck cancer	0.00213	0.00213	CcSEcCtD
Foscarnet—Fatigue—Docetaxel—head and neck cancer	0.00212	0.00212	CcSEcCtD
Foscarnet—Pain—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Foscarnet—Constipation—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Foscarnet—Feeling abnormal—Docetaxel—head and neck cancer	0.00203	0.00203	CcSEcCtD
Foscarnet—Nausea—Fluorouracil—head and neck cancer	0.00202	0.00202	CcSEcCtD
Foscarnet—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00201	0.00201	CcSEcCtD
Foscarnet—Abdominal pain—Docetaxel—head and neck cancer	0.00194	0.00194	CcSEcCtD
Foscarnet—Body temperature increased—Docetaxel—head and neck cancer	0.00194	0.00194	CcSEcCtD
Foscarnet—Asthenia—Docetaxel—head and neck cancer	0.00176	0.00176	CcSEcCtD
Foscarnet—Pruritus—Docetaxel—head and neck cancer	0.00174	0.00174	CcSEcCtD
Foscarnet—Diarrhoea—Docetaxel—head and neck cancer	0.00168	0.00168	CcSEcCtD
Foscarnet—Dizziness—Docetaxel—head and neck cancer	0.00163	0.00163	CcSEcCtD
Foscarnet—Vomiting—Docetaxel—head and neck cancer	0.00156	0.00156	CcSEcCtD
Foscarnet—Rash—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Foscarnet—Dermatitis—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Foscarnet—Headache—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Foscarnet—Nausea—Docetaxel—head and neck cancer	0.00146	0.00146	CcSEcCtD
